Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences cash
Cash and short-term investments held at the end of each period.
Sight Sciences's cash was $79.75M at Jun 30, 2026. For fiscal 2025 it was $91.97M, down 23.6% from the year before. The highest annual figure on record is $260.69M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.97M | -23.6% |
| FY2024 | Dec 31, 2024 | $120.36M | -12.9% |
| FY2023 | Dec 31, 2023 | $138.13M | -25.3% |
| FY2022 | Dec 31, 2022 | $185.00M | -29.0% |
| FY2021 | Dec 31, 2021 | $260.69M | +323.8% |
| FY2020 | Dec 31, 2020 | $61.51M | +189.6% |
| FY2019 | Dec 31, 2019 | $21.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $79.75M | -21.4% |
| Q1 FY2026 | Mar 31, 2026 | $84.96M | -21.9% |
| Q4 FY2025 | Dec 31, 2025 | $91.97M | -23.6% |
| Q3 FY2025 | Sep 30, 2025 | $92.37M | -22.1% |
| Q2 FY2025 | Jun 30, 2025 | $101.50M | -14.1% |
| Q1 FY2025 | Mar 31, 2025 | $108.77M | -14.5% |
| Q4 FY2024 | Dec 31, 2024 | $120.36M | -12.9% |
| Q3 FY2024 | Sep 30, 2024 | $118.56M | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $118.18M | -23.5% |
| Q1 FY2024 | Mar 31, 2024 | $127.28M | -23.9% |
| Q4 FY2023 | Dec 31, 2023 | $138.13M | -25.3% |
| Q3 FY2023 | Sep 30, 2023 | $144.50M | -27.7% |
| Q2 FY2023 | Jun 30, 2023 | $154.52M | -29.8% |
| Q1 FY2023 | Mar 31, 2023 | $167.34M | -29.9% |
| Q4 FY2022 | Dec 31, 2022 | $185.00M | -29.0% |
| Q3 FY2022 | Sep 30, 2022 | $199.82M | -26.4% |
| Q2 FY2022 | Jun 30, 2022 | $220.10M | +518.7% |
| Q1 FY2022 | Mar 31, 2022 | $238.59M | +393.7% |
| Q4 FY2021 | Dec 31, 2021 | $260.69M | +323.8% |
| Q3 FY2021 | Sep 30, 2021 | $271.48M | +911.3% |
| Q2 FY2021 | Jun 30, 2021 | $35.57M | -0.5% |
| Q1 FY2021 | Mar 31, 2021 | $48.33M | +127.6% |
| Q4 FY2020 | Dec 31, 2020 | $61.51M | – |
| Q3 FY2020 | Sep 30, 2020 | $26.84M | – |
| Q2 FY2020 | Jun 30, 2020 | $35.75M | – |
| Q4 FY2019 | Dec 31, 2019 | $21.24M | – |
See a number that looks wrong?